Tab. 2.
Gene | Protein | Effect of aberrant methylation |
---|---|---|
APC | Adenomatous polyposis coli | increased of WNT signaling |
ADAM23 | Disintegrin and metalloproteinase domain- containing protein 23 | alteration in cell-cell and cell-matrix interactions |
CDKN2A | p14/ARF | decreased p53 activation |
CDKN2A | p16/INK4a | increased cell proliferation |
CDH1 | E-cadherin | loss of cell adhesion |
CDH13 | cadherin-13 | increased PI3K/Akt/mTOrR signaling |
CXCL12 | C-X-C Motif Chemokine Ligand 12 | increased tumor cell metastases |
DCC | deleted in colorectal cancer | inhibition of apoptosis |
DAPK | death associated protein kinase | interferon gamma signaling and TNF alpha signaling |
HLTF | Helicase-like transcriptor factor | alteration in chromatin structure |
HACE1 | HECT domain and ankyrin repeat-containing ubiquitin ligase | loss of tumor suppressor gene |
IRF8 | Interferon Regulatory Factor 8 | interferon signaling |
MLHl† | MutL Homolog 1 | microsatellite instability |
MGMT | O-6-Methylguanine-DNA Methyltransferase | Increased G>A mutation frequency |
MINT clones | Methylated in tumor locus | NA |
RASSFla | Ras association domain family 1 (isoform A) | Increased RAS/RAF/MAPK signaling |
RUNX3*† | Runt-related transcription factor 3 | Decreased TGF-beta signaling |
SOCS1*† | Suppressor Of Cytokine Signaling 1 | increased of JAK/STAT3 signaling |
SFRP1-2 | Secreted Frizzled Related Protein 1 | Increased WNT signaling |
SEPT9 | Septin 9 | Impaired cytokinesis |
SERF1 | Small EDRK-Rich Factor 1A | Increased WNT signaling |
VIM | Vimentin | NA |
NEUROG1*† | Neurogenin 1 | Increased WNT signaling |
CRABPl† | Cellular Retinoic Acid Binding Protein 1 | Increased WNT signaling |
IGF2*† | Insulin Like Growth Factor 2 | Increased WNT signaling |
CACNA1G*† | Calcium Voltage-Gated Channel Subunit Alpha1 G | Increased WNT signaling |
SLC5A8 | Solute Carrier Family 5 Member 8 | NA |
Ogino’s panel to define CIMP status
Weisenberger’s panel to define CIMP status